These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 12794766

  • 1. Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines.
    Mimeault M, Pommery N, Hénichart JP.
    Int J Cancer; 2003 Aug 10; 106(1):116-24. PubMed ID: 12794766
    [Abstract] [Full Text] [Related]

  • 2. Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines.
    Mimeault M, Jouy N, Depreux P, Hénichart JP.
    Prostate; 2005 Feb 01; 62(2):187-99. PubMed ID: 15389789
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells.
    Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK.
    Int J Cancer; 2006 Feb 15; 118(4):1022-31. PubMed ID: 16108016
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells.
    Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK.
    Mol Cancer Ther; 2007 Mar 15; 6(3):967-78. PubMed ID: 17363490
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM.
    Cancer Res; 2004 Aug 01; 64(15):5355-62. PubMed ID: 15289342
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines.
    Putz T, Culig Z, Eder IE, Nessler-Menardi C, Bartsch G, Grunicke H, Uberall F, Klocker H.
    Cancer Res; 1999 Jan 01; 59(1):227-33. PubMed ID: 9892211
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary cultures.
    Vicentini C, Festuccia C, Gravina GL, Angelucci A, Marronaro A, Bologna M.
    J Cancer Res Clin Oncol; 2003 Mar 01; 129(3):165-74. PubMed ID: 12712332
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B, Chang CM, Yuan M, McKenna WG, Shu HK.
    Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544
    [Abstract] [Full Text] [Related]

  • 17. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X, Grasso AW, Kung HJ, Agarwal R.
    Cancer Res; 1998 May 01; 58(9):1920-9. PubMed ID: 9581834
    [Abstract] [Full Text] [Related]

  • 18. Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features.
    Engedal N, Saatcioglu F.
    Prostate; 2001 Mar 01; 46(4):289-97. PubMed ID: 11241551
    [Abstract] [Full Text] [Related]

  • 19. Ceramide induces cell death in the human prostatic carcinoma cell lines PC3 and DU145 but does not seem to be involved in Fas-mediated apoptosis.
    Gewies A, Rokhlin OW, Cohen MB.
    Lab Invest; 2000 May 01; 80(5):671-6. PubMed ID: 10830777
    [Abstract] [Full Text] [Related]

  • 20. Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.
    Pu YS, Hsieh MW, Wang CW, Liu GY, Huang CY, Lin CC, Guan JY, Lin SR, Hour TC.
    Biochem Pharmacol; 2006 Mar 14; 71(6):751-60. PubMed ID: 16413505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.